114 related articles for article (PubMed ID: 9109046)
1. Pharmacokinetics and pharmacodynamics of pirmenol enantiomers in coronary artery ligated dogs.
Janiczek N; Smith DE; Chang T; Ventura A; Mertz TE
J Pharm Sci; 1997 Apr; 86(4):443-9. PubMed ID: 9109046
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective high-performance liquid chromatographic assay for pirmenol enantiomers in dog plasma.
Janiczek N; Bockbrader HN; Chang T; Amidon GL; Smith DE
J Chromatogr; 1991 Nov; 571(1-2):179-87. PubMed ID: 1810946
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of oral pirmenol.
Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
[TBL] [Abstract][Full Text] [Related]
5. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
Mertz TE; Kaplan HR
J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology and pharmacokinetics of pirmenol.
Reiter MJ
Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
[TBL] [Abstract][Full Text] [Related]
7. Pirmenol: preclinical pharmacology.
Kaplan HR; Mertz TE; Steffe TJ
Angiology; 1988 Mar; 39(3 Pt 2):281-92. PubMed ID: 3281517
[TBL] [Abstract][Full Text] [Related]
8. Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs.
Mertz TE; Steffe TJ
J Cardiovasc Pharmacol; 1980; 2(5):527-41. PubMed ID: 6157947
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of pirmenol.
Kaplan HR; Mertz TE; Steffe TJ
Am J Cardiol; 1987 Jun; 59(16):2H-9H. PubMed ID: 3591710
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects of pirmenol, its metabolite 2, and enantiomers, on cardiac Purkinje fibers.
Lee JH; Rosen MR
J Cardiovasc Pharmacol; 1993 Sep; 22(3):416-22. PubMed ID: 7504132
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ibutilide and its enantiomers in dogs.
Hsu CY; Walters RR
Chirality; 1996; 8(1):18-23. PubMed ID: 8845277
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
Hashimoto K; Watanabe K; Sugiyama A
Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of the antiarrhythmic drug pirmenol.
Phillips HR; Stack RS; Davis DD; Morris KG; Lee KL; Shand DG; Pritchett EL
Clin Pharmacol Ther; 1982 Aug; 32(2):235-9. PubMed ID: 7094511
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pirmenol in young and elderly subjects.
Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR
Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical pharmacokinetics of pirmenol.
Chang T
Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
[TBL] [Abstract][Full Text] [Related]
18. Enhanced pirmenol elimination by rifampin.
Stringer KA; Cetnarowski AB; Goldfarb A; Lebsack ME; Chang T; Sedman AJ
J Clin Pharmacol; 1988 Dec; 28(12):1094-7. PubMed ID: 3243925
[TBL] [Abstract][Full Text] [Related]
19. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
Nieminen MS; Toivonen LK; Manninen V; Frick MH
Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
Aso R; Ohashi K; Katoh T; Ogata H
Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
